logoTry Persana

Talus Bio - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Talus Bio including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Talus Bio company logo

Gene regulator profiling in live cells for drug development

Talus Bio is a technology-enabled therapeutics company focused on discovering small molecules that modulate transcription factor activity in live human cells.

HeadquartersSeattle, United States
Team size11-50
Founded2020

What is Talus Bio? - Company Overview & Details

Talus Bio is Talus Bio is a technology-enabled therapeutics company focused on discovering small molecules that modulate transcription factor activity in live human cells. Founded in 2020, the company is headquartered in Seattle, United States.

Who Founded Talus Bio?

Talus Bio was founded by Alex Federation, Lindsay Pino.

Who are the Key Executives at Talus Bio? - Leadership Team

Talus Bio is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Talus Bio

Alex FederationCEO

Chief Technology Officer (CTO) of Talus Bio

Lindsay PinoCTO

About Alex Federation - CEO of Talus Bio

Alex Federation serves as the Chief Executive Officer of Talus Bio, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Talus Bio Company Details & Key Information

Where is Talus Bio located?

Talus Bio is headquartered in Seattle, United States.

How many employees does Talus Bio have?

Talus Bio has 11-50 employees.

When was Talus Bio founded?

Talus Bio was founded in 2020.

Talus Bio Official Website

How much funding has Talus Bio raised?

Talus Bio has raised $19.7 Million across 6 funding rounds. The most recent funding was completed on 2024-09-20.

Funding Overview

Talus Bio has raised a total of $19.7 million in funding, including recent investments to advance its drug discovery platform.

$19.7 Million
Total Funding Raised
6
Funding Rounds
2024-09-20
Latest Round

Talus Bio Funding History

Seed
2024-09-20
$11.2 Million
Grant
2023-09-18
$4.3 Million

Who are the key investors in Talus Bio?

Talus Bio is backed by 2 key investors including Two Bear Capital, Andy Hill Cancer Research Endowment (CARE) Fund. These investors focus on Biotechnology, Life Sciences, Cancer Research sectors.

Talus Bio Investor Overview

2
Key Investors
3
Focus Areas
2
Notable Investments

Complete List of Talus Bio Investors

Two Bear Capital

Invests in startups focused on impactful technologies.

Investment Focus
Biotechnology
Life Sciences
Notable Portfolio Companies
Talus Bio

Andy Hill Cancer Research Endowment (CARE) Fund

Promotes cancer research through strategic grants.

Investment Focus
Cancer Research
Notable Portfolio Companies
Talus Bio

What sectors do Talus Bio investors focus on?

The investors backing Talus Bio primarily focus on Biotechnology, Life Sciences, Cancer Research sectors.

Biotechnology
Life Sciences
Cancer Research

Featured Investor: Two Bear Capital

Two Bear Capital

Invests in startups focused on impactful technologies.

Notable Investments: Talus Bio

What are Talus Bio's future plans?

Talus Bio Talus Bio is focused on expanding its drug development pipeline targeting transcription factors.

Talus Bio Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Talus Bio face?

Talus Bio has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Talus Bio

1

Securing partnerships for further development

2

Navigating complex regulatory landscapes

What opportunities does Talus Bio have?

Talus Bio has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Talus Bio

1

Advancing partnerships in drug discovery

2

Expanding their technology platform

Talus Bio Strategic Position Summary

Key Focus Areas

Talus Bio is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Talus Bio?

Talus Bio has 2 recent news updates covering key business developments and market activities.

Talus Bio News Overview

2
Recent Articles
Active
Media Coverage
2025-04-25
Latest Update

What is Talus Bio in the news for?

Talus Bio is currently featured in news for Talus Bioscience, Inc. attends event AACR Annual Meeting 2025. and other significant business developments.

Recent News Articles About Talus Bio

Article 1
2025-04-25

Talus Bioscience, Inc. attends event AACR Annual Meeting 2025.

Talus Bio presents preclinical data on transcription factor therapeutic programs at the AACR Annual Meeting 2025.

biospace.com
Read News
Article 2
2024-12-10

Talus Bioscience, Inc. hires Chris Joyce as vice president of business development.

Talus Bio hired Chris Joyce as its new vice president of business development to help advance drug discovery.

geekwire.com
Read News

Talus Bio FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Talus Bio including information about founders, CEO, funding history, investors, headquarters location, and company details. 19 frequently asked questions covering key information about the company.

Talus Bio Questions & Answers - Company Information

Q1

What is Talus Bio?

Talus Bio is a technology-enabled therapeutics company focused on discovering small molecules that modulate transcription factor activity in live human cells.

Q2

Who founded Talus Bio?

Talus Bio was founded by Alex Federation, Lindsay Pino.

Q3

Who is the CEO of Talus Bio?

The CEO of Talus Bio is Alex Federation. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Talus Bio raised?

Talus Bio has raised a total of $$19.7 Million across 6 funding rounds. The most recent funding was completed on 2024-09-20.

Q5

Who are the investors in Talus Bio?

Talus Bio's key investors include Two Bear Capital, Andy Hill Cancer Research Endowment (CARE) Fund.

Q6

Where is Talus Bio headquartered?

Talus Bio is headquartered in Seattle, United States.

Q7

When was Talus Bio founded?

Talus Bio was founded in 2020.

Q8

How many employees does Talus Bio have?

Talus Bio has 11-50 employees.

Q9

What is Talus Bio's official website?

You can visit Talus Bio's official website at http://talus.bio.

Q10

What was Talus Bio's latest funding round?

Talus Bio's latest funding round was a Seed round of $$11.2 Million completed on 2024-09-20.

Q11

Who is founder?

Alex Federation

Q12

Who is cto?

Lindsay Pino

Q13

What does the company do?

Talus Bio is focused on discovering small molecules that modulate transcription factor activity in live human cells.

Q14

How much funding?

$19.7 Million

Q15

Latest funding date?

2024-09-20

Q16

Who are the investors?

Two Bear Capital Andy Hill Cancer Research Endowment (CARE) Fund

Q17

What are the challenges?

Securing partnerships for further development Navigating complex regulatory landscapes

Q18

What are the opportunities?

Advancing partnerships in drug discovery Expanding their technology platform

Q19

Latest news?

Talus Bio presents preclinical data on transcription factor therapeutic programs at the AACR Annual Meeting 2025. Talus Bio hired Chris Joyce as its new vice president of business development to help advance drug discovery.

More Information About Talus Bio

For additional details about Talus Bio, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.